ING Groep NV reduced its stake in Lam Research Corporation by 4.6%, selling 55,408 shares and now holds 1,156,563 shares valued at $84 million. Lam Research reported earnings of $1.33 per share, surpassing expectations, with $5.17 billion in revenue. The company declared a $0.23 quarterly dividend with a 1.0% yield and a 22.12% payout ratio. Multiple institutional investors adjusted their positions in Lam Research, with institutional ownership accounting for 84.61% of the stock. Lam Research has a $123.27 billion market cap, a 23.17 PE ratio, and a 33.6% year-over-year revenue increase.

Coca-Cola HBC AG and its subsidiary Coca-Cola HBC Finance B.V. replaced their €800 million credit facility with a new €1.2 billion sustainability-linked facility, which includes a five-year term and an optional two-year extension. The arrangement, coordinated by BNP Paribas and Citi, involves multiple international banks and represents a 50% increase in credit capacity.

ING Groep NV increased its stake in Arista Networks by 188.4% during Q1, owning 0.07% of the company's stock. Other hedge funds also adjusted their positions, while analyst ratings and insider transactions were highlighted. Arista Networks reported strong Q2 earnings, with a 27.6% revenue increase and a stock buyback plan approved.

ING Groep N.V. announced a dividend of €0.35 per share to be paid on August 11, 2025, representing 5.4% of the current stock price. The payout ratio is 69% based on recent earnings, with forecasts indicating 72.8% EPS growth over three years and a potential future payout ratio of 51%. The company has maintained a dividend track record since 2015, with annual dividends increasing from €0.12 to €1.06, reflecting a 24% CAGR.

ING Groep NV increased its stake in Johnson & Johnson by 116.3%, owning 1.1 million shares valued at $188.2 million. Johnson & Johnson reported a 2nd quarter EPS of $2.77, exceeding estimates, with a 5.8% revenue increase year-over-year and a $1.30 quarterly dividend. Multiple institutional investors and hedge funds adjusted their holdings in JNJ, while the company's stock has a market cap of $402.99 billion and a 3.1% yield. Analysts provided mixed ratings, with some upgrading the stock.